Carl Zeiss Meditec AG (CZMWF)
OTC
Closed
Oct 6, 2026
Day's Range
35.0052 wk Range
26.42Overview - CZMWF - Carl Zeiss Meditec AG
Key Statistics
Valuation
Enterprise Value
4.38B
P/E (Trailing)
‪24.49‬
P/E (Forward)
‪14.63‬
PEG Ratio
‪-0.18‬
Price / Sales (TTM)
‪1.53‬
Price / Book
‪1.40‬
EV / EBITDA
‪17.73‬
Profitability
Gross Margin
‪48.62%‬
Profit Margin
‪5.57%‬
Operating Margin
‪11.06%‬
Return on Assets
‪4.15%‬
Return on Equity
‪6.63%‬
Ownership
Shares Outstanding
87.53M
Float
34.18M
Held by Insiders
‪59.13%‬
Held by Institutions
‪19.19%‬
Price stats
Beta
‪1.35‬
50-Day Avg
‪35.99‬
200-Day Avg
‪34.53‬
Dividends
Payout Ratio
‪43.80%‬
Frequency
Annual
Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - CZMWF - Carl Zeiss Meditec AG
Peers - CZMWF - Carl Zeiss Meditec AG
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on OTC.
Profile Summary - CZMWF - Carl Zeiss Meditec AG
About
Carl Zeiss Meditec AG is a leading medical technology company specializing in ophthalmology and microsurgery solutions. Headquartered in Jena, Germany, and founded in 1846, it operates as a subsidiary of the ZEISS Group, delivering innovative products for diagnosing and treating eye diseases such as ametropia,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
